Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case report

Anaplastic lymphoma kinase (ALK) gene fusion, an important driver gene alteration leading to the development of lung cancer, occurs in 5% of nonsmall cell lung cancer (NSCLC) cases in China. In addition to echinoderm microtubule-associated protein-like 4 (EML4)-ALK, which is the most common type of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Lei, Ding, Guozheng, Wang, Muzi, Ye, Yuanzi, Yan, Xuebo, Ding, Peishan, Wang, Jiong, Zhang, Yanbei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410632/
https://www.ncbi.nlm.nih.gov/pubmed/36042596
http://dx.doi.org/10.1097/MD.0000000000030255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410632/
https://www.ncbi.nlm.nih.gov/pubmed/36042596
http://dx.doi.org/10.1097/MD.0000000000030255

Ejemplares similares